Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.32 USD | -1.12% | +1.55% | +26.75% |
Jun. 04 | Oppenheimer Raises Price Target on Crinetics Pharmaceuticals to $74 From $55, Maintains Outperform Rating | MT |
Jun. 03 | Transcript : Crinetics Pharmaceuticals, Inc. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.75% | 3.61B | |
+53.81% | 59.28B | |
+41.42% | 40.94B | |
-5.44% | 40.17B | |
-5.16% | 28.69B | |
+12.58% | 26.63B | |
-21.09% | 18.89B | |
+30.84% | 12.46B | |
+0.04% | 12.42B | |
+26.49% | 12.26B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Transcript : Crinetics Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024